UCB (umbilical cord blood) as a resource of MSCs (mesenchymal stem cells) is widely accepted, but the quantity and characteristics of UCB-MSCs from different gestational ages have not been well studied. We have quantified the number of MSCs in UCB at different gestational ages using a multi-colour flowcytometer and compared the cell proliferation rates of these UCB-MSCs. Defining MSCs as CD44+/CD105+/CD342/CD45 population, their numbers declined in the UCB at the gestational age. Proliferation rates were significantly higher in UCB before term than at full term. Non-full term UCB samples may be a better source of MSCs.
Introduction
UCB (umbilical cord blood) contains abundant stem cells that can be successfully isolated for use in treating haematopoietic disorders. MSCs (mesenchymal stem cells) are also present in UCB and have similar phenotypes as bone marrow-derived MSCs with multi-lineage differentiation potential (Kern et al., 2006; Manca et al., 2008) . Compared with bone marrow MSCs, UCBMSCs are readily available, easy to harvest and evoke little ethic controversy. However, isolation of MSCs from full-term UCB has not always been successful due to the sparse population at fullterm UCB. The frequency of MSCs in full-term UCB is only 0.00003% of nucleated cells (Campagnoli et al., 2001 ). The number of MSCs from bone marrow declines with age (Stenderup et al., 2003) , but the number of MSCs in UCB at different gestational ages remains unknown. Therefore, we quantified the number of UCB-MSCs at different gestational ages by flowcytometer and investigated the rate of their proliferation.
Materials and methods

Collection of UCB samples and multi-colour flowcytometry
A total 52 UCB samples of full-term (n512; 37-40 weeks) and non-full-term (n540; 28-36 weeks) were collected from healthy women (average age 24¡2 years) who have undergone Caesarean, with ethical approval and written informed consent in Shengjing Hospital of China Medical University, Shenyang, China. The number of MSCs in UCB was quantified by multicolour flowcytometer (BD LSRFortessa TM ). In brief, three test tubes containing 100 ml UCB were prepared for each sample. Erythrocytes were first removed with FACS lysing solution (BD). CD34 PERCP (Biolegend), CD44 PE (Santa Cruz), CD45 PECY7 and CD105 FITC (Biolegend) antibodies were added to two tubes, but none to the third as the negative control. The tubes were incubated for 10 min at room temperature and centrifuged at 400-500 g for 5 min. The supernatant was discarded, and the cells were washed twice with PBS buffer. Resuspended cells in 500 ml PBS were analysed by flowcytometry using BD's analysis software.
Culture of UCB-MSCs and immunocytochemistry
Samples of 10-20 ml UCB were layered on to Lymphoprep TM (1.077 g/ml; Nycomed) for centrifugation at 850 g for 25 min. Isolated mononuclear cells, suspended in DMEM (Dulbecco's modified Eagle's medium) containing 10% fetal bovine serum, 100 units/ml penicillin, 100 mg/ml streptomycin, 2.5 mg/ml fungizone and 2 mM L-glutamine, were seeded into T75 flasks at 1610 5 cells/cm 2 and incubated at 37uC in a humidified atmosphere with 5% CO 2 /95% air. MSCs successfully cultured from each sample were selected for analysis of growth kinetics. For immunocytochemical examination, UCB-MSCs were fixed in 4% (w/v) paraformaldehyde for 24 h and washed by PBS. The cells were blocked with 5% BSA for 1 h at room temperature before being incubated with 1:100 CD45 and CD90 rabbit antihuman polyclonal antibody (Santa Cruz) overnight at 4uC. After washing in PBS, cells were incubated with PE (phycoerythrin)-labelled goat-anti-rabbit antibody at room temperature for 1 h in the dark. After washing in PBS, the cells were examined under a fluorescence microscope.
Results
Lysed whole cord blood was examined for cell characteristics, cell size (FSC) being plotted against the presence of cytoplasmic granules (SSC). The cells were divided into three distinct types, lymphocytes, monocytes and granulocytes ( Figure 1A ). Positive or negative expression of surface CD markers (CD44+/CD105+/ CD342/CD45) was defined by the intensity of their fluorescence.
CD452 cells accounted for 21% of the total ( Figure 1B ). C34 PERCP expression estimation in CD452 cells indicated that 99% were also negative for CD34 ( Figure 1C ). CD342/CD452 cells were examined for their expression of CD105 and CD44. CD342/CD452 cells can be classified into four zones according to their CD44-PE and CD105-FITC fluorescence intensity ( Figure 2A ). Q2 zone contained CD44+/CD105+/CD342/CD452 cells, which represented MSCs. All samples were sorted from the different groups at intervals of 3 weeks of gestation. The average number of MSCs calculated based on every 10 6 nucleated cells was examined. MSCs gradually decreased as gestation proceeded ( Figure 2B ). Full-term and non-full-term cord blood MSCs were cultured in vitro to explore their character. In the 12 full-term UCB samples, only one gave rise to fibroblastic and adherent cells after 96 h in 
Discussion
MSCs isolated from multiple tissues have different frequency and expansion potentials, but their basic characteristics are similar (Kern et al., 2006) . UCB provides a new resource for these young progenitor cells, but the low frequency of isolation has been a hurdle in their clinical applications. This low yield suggested that MSCs are sparse in UCB, the previous methods estimating MSCs by counting the number of clones per 10 6 cells mononuclear cells plated (Campagnoli et al., 2001) , giving an inaccurate reflection of the actual quantity of MSCs because some may have been lost during the isolation and others being non-adherent. Flowcytometery has been used to quantify the number of MSCs from bone marrow and UCB, using a combination of CD markers (Martins et al., 2009 ). We used a single-tube multi-colour fluorescence staining technique to analyse expression of CD44, CD105, CD34 and CD45 in the mononuclear cells at different Figure 3 Immunohistochemical staining of CD markers confirms the phenotype of UCB-MSCs UCB-MSCs that are CD452 (A), but CD90+ (B). MSCs cultured from UCB were fixed and stained with PE conjugated antibodies, the nuclei being counterstained with DAPI 6400. 
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